Skip to main content

Table 1 Characteristics of LT recipients, overall and by major etiology

From: Changing trends in liver transplantation indications in Saudi Arabia: from hepatitis C virus infection to nonalcoholic fatty liver disease

 

Overall

NASH

HCV

HBV

Wilson's disease

PSC

AIH

SCH

Other

N transplants

1009

248 (24.6%)

287 (28.4%)

224 (22.2%)

23 (2.3%)

28 (2.8%)

89 (8.8%)

21 (2.1%)

89 (8.8%)

Age [Median (IQR)]

55 (45–62)

59 (53–64)

58 (52–64)

54 (48–61)

23 (19–29)

40 (32–47)

32 (23–45)

60 (57–64)

34 (25–54)

Male [n (%)]

634 (62.8%)

174 (70.2%)

162 (56.5%)

167 (74.6%)

12 (52.2%)

13 (46.4%)

38 (42.7%)

21 (100.0%)

47 (52.8%)

BMI [Median]

26.1 (22.9–30.5)

26.6 (23.6–32.0)

26.9 (23.9–30.8)

27.3 (23.4–31.3)

22.8 (20.7–24.3)

23.5 (20.1–27.2)

24.2 (21.6–28.2)

25.9 (23.0–29.3)

23.6 (20.1–27.3)

BMI group [n (%)]

         

Underweight

49 (4.9%)

6 (2.4%)

7 (2.4%)

6 (2.7%)

4 (17.4%)

4 (14.3%)

7 (7.9%)

0 (0.0%)

15 (16.9%)

Normal weight

366 (36.3%)

78 (31.5%)

90 (31.4%)

73 (32.6%)

13 (56.5%)

14 (50.0%)

45 (50.6%)

10 (47.6%)

43 (48.3%)

Pre-obesity

308 (30.5%)

84 (33.9%)

99 (34.5%)

69 (30.8%)

3 (13.0%)

8 (28.6%)

20 (22.5%)

7 (33.3%)

18 (20.2%)

Obesity (class 1)

194 (19.2%)

52 (21.0%)

62 (21.6%)

53 (23.7%)

1 (4.4%)

1 (3.6%)

13 (14.6%)

4 (19.1%)

8 (9.0%)

Obesity (class 2)

60 (6.0%)

15 (6.1%)

19 (6.6%)

18 (8.0%)

1 (4.4%)

0 (0.0%)

4 (4.5%)

0 (0.0%)

3 (3.4%)

Obesity (class 3)

32 (3.2%)

13 (5.2%)

10 (3.5%)

5 (2.2%)

1 (4.4%)

1 (3.6%)

0 (0.0%)

0 (0.0%)

2 (2.3%)

Waitlist time [Median days]

49 (15–139)

42 (20–103)

58 (15–160)

49 (15–141)

75 (10–110)

64 (24–153)

36 (14–156)

102 (42–131)

49 (15–155)

LT from living donor [n (%)]

628 (62.2%)

179 (72.2%)

159 (55.4%)

150 (67.0%)

10 (43.5%)

19 (67.9%)

47 (52.8%)

16 (76.2%)

48 (53.9%)

MELD score [Median]

22 (16–25)

22 (17–24)

20 (15–22)

22 (17–25)

30 (17–37)

21 (16–26)

24 (19–31)

20 (17–22)

24 (18–30)

HCC candidate [n (%)]

282 (28.0%)

59 (23.8%)

123 (42.9%)

87 (38.8%)

1 (4.4%)

0 (0.0%)

2 (2.3%)

4 (19.1%)

6 (6.7%)

  1. LT, liver transplant; NASH, nonalcoholic steatohepatitis; HCV, hepatitis C virus; HBV, hepatitis B virus; PSC, primary sclerosing cholangitis; AIH, autoimmune hepatitis; SCH, schistosomiasis; IQR, interquartile range; BMI, body mass index; MELD, model for end-stage liver disease; HCC, hepatocellular carcinoma